Talis Biomedical Corporation Talis Biomedical Announces 1for15 Reverse Stock Split

REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will effect a 1-for-15…Read More